PureTech Regulatory News (PRTC)

PureTech Information

Buy PRTC Shares
Add PRTC to Watchlist
Add PRTC to Alert

Share Price Information for PureTech (PRTC)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 227.50

Bid: 226.50

Ask: 228.00

Change: 2.00 (0.89%)

Spread: 1.50 (0.662%)

Open: 228.00

High: 228.50

Low: 224.50

Prev. Close: 225.50

Last checked at -

Transaction in Own Shares

11 Jan 2024 07:00

RNS Number : 3049Z

PureTech Health PLC

11 January 2024

PureTech Health plc

Transaction in Own Shares

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

Date of purchase:	10 January 2024

Number of ordinary shares purchased:	117,693

Highest price paid per share:	207.50p

Lowest price paid per share:	199.40p

Volume weighted average price paid per share:	203.71p

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 18,089,472 ordinary shares in treasury and has 271,378,687 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 271,378,687 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

Transaction Date	Transaction Time	Volume	Price (GBp)	Platform	Transaction Reference Number
10/01/2024	08:01:33	386	207.5	AQXE	00384872933TRLO0.1.1
10/01/2024	08:01:33	1084	207	XLON	00384872934TRLO0.1.1
10/01/2024	08:01:34	542	205.5	CHIX	00384872937TRLO0.1.1
10/01/2024	08:01:34	542	205.5	BATE	00384872938TRLO0.1.1
10/01/2024	08:40:41	542	205	XLON	00384881503TRLO0.1.1
10/01/2024	08:40:41	30	205	CHIX	00384881504TRLO0.1.1
10/01/2024	08:40:41	378	205	XLON	00384881505TRLO0.1.1
10/01/2024	08:40:41	356	205	CHIX	00384881506TRLO0.1.1
10/01/2024	08:40:41	164	205	XLON	00384881507TRLO0.1.1
10/01/2024	08:40:41	542	205	XLON	00384881508TRLO0.1.1
10/01/2024	08:40:41	39	205	XLON	00384881510TRLO0.1.1
10/01/2024	08:40:41	86	205	XLON	00384881509TRLO0.1.1
10/01/2024	08:40:41	417	205	XLON	00384881511TRLO0.1.1
10/01/2024	08:40:41	542	205	XLON	00384881512TRLO0.1.1
10/01/2024	08:40:41	156	205	CHIX	00384881513TRLO0.1.1
10/01/2024	08:40:41	418	204.5	XLON	00384881514TRLO0.1.1
10/01/2024	08:40:41	17	204.5	TRQX	00384881515TRLO0.1.1
10/01/2024	08:40:41	234	204.5	TRQX	00384881516TRLO0.1.1
10/01/2024	08:47:35	350	204	CHIX	00384882591TRLO0.1.1
10/01/2024	08:47:35	1462	204	XLON	00384882592TRLO0.1.1
10/01/2024	08:47:35	90	204	CHIX	00384882593TRLO0.1.1
10/01/2024	08:47:35	102	204	CHIX	00384882594TRLO0.1.1
10/01/2024	08:47:35	174	204	XLON	00384882595TRLO0.1.1
10/01/2024	08:47:35	83	204	XLON	00384882596TRLO0.1.1
10/01/2024	08:47:35	449	204	XLON	00384882597TRLO0.1.1
10/01/2024	08:47:35	105	203.5	BATE	00384882598TRLO0.1.1
10/01/2024	08:54:25	437	203.5	BATE	00384883674TRLO0.1.1
10/01/2024	08:56:50	72	203	XLON	00384883935TRLO0.1.1
10/01/2024	08:56:50	138	203	XLON	00384883936TRLO0.1.1
10/01/2024	08:56:50	1571	203	XLON	00384883937TRLO0.1.1
10/01/2024	08:56:50	7	203	XLON	00384883938TRLO0.1.1
10/01/2024	08:56:50	380	203	XLON	00384883939TRLO0.1.1
10/01/2024	08:56:50	251	203	TRQX	00384883940TRLO0.1.1
10/01/2024	09:01:59	238	202	AQXE	00384884965TRLO0.1.1
10/01/2024	09:01:59	112	202	AQXE	00384884966TRLO0.1.1
10/01/2024	09:01:59	36	202	AQXE	00384884967TRLO0.1.1
10/01/2024	09:01:59	1208	202	XLON	00384884968TRLO0.1.1
10/01/2024	09:01:59	542	202	XLON	00384884969TRLO0.1.1
10/01/2024	09:06:39	32	201	XLON	00384885619TRLO0.1.1
10/01/2024	09:24:16	542	201	CHIX	00384888409TRLO0.1.1
10/01/2024	09:24:16	30	201	BATE	00384888410TRLO0.1.1
10/01/2024	09:24:16	35	201	BATE	00384888412TRLO0.1.1
10/01/2024	09:24:16	91	201	BATE	00384888411TRLO0.1.1
10/01/2024	09:24:16	140	201	BATE	00384888413TRLO0.1.1
10/01/2024	09:24:16	91	201	BATE	00384888414TRLO0.1.1
10/01/2024	09:24:16	155	201	BATE	00384888415TRLO0.1.1
10/01/2024	09:24:16	575	201	XLON	00384888416TRLO0.1.1
10/01/2024	09:24:16	1561	201	XLON	00384888417TRLO0.1.1
10/01/2024	09:25:28	542	199.6	XLON	00384888577TRLO0.1.1
10/01/2024	09:25:29	542	199.6	XLON	00384888578TRLO0.1.1
10/01/2024	09:49:57	542	201	XLON	00384892275TRLO0.1.1
10/01/2024	09:49:57	181	201	XLON	00384892276TRLO0.1.1
10/01/2024	09:49:57	119	201	XLON	00384892279TRLO0.1.1
10/01/2024	09:49:57	345	201	XLON	00384892278TRLO0.1.1
10/01/2024	09:49:57	439	201	XLON	00384892280TRLO0.1.1
10/01/2024	09:49:57	542	201	XLON	00384892281TRLO0.1.1
10/01/2024	10:01:49	542	201	XLON	00384894712TRLO0.1.1
10/01/2024	10:01:49	1084	201	XLON	00384894713TRLO0.1.1
10/01/2024	10:30:20	302	200.5	BATE	00384899461TRLO0.1.1
10/01/2024	10:30:20	240	200.5	BATE	00384899463TRLO0.1.1
10/01/2024	10:30:20	213	200.5	CHIX	00384899462TRLO0.1.1
10/01/2024	10:30:20	47	200.5	BATE	00384899464TRLO0.1.1
10/01/2024	10:30:20	297	200.5	CHIX	00384899466TRLO0.1.1
10/01/2024	10:30:20	21	200.5	CHIX	00384899467TRLO0.1.1
10/01/2024	10:30:20	323	200.5	BATE	00384899468TRLO0.1.1
10/01/2024	10:30:20	23	200.5	BATE	00384899469TRLO0.1.1
10/01/2024	10:30:20	542	200.5	XLON	00384899470TRLO0.1.1
10/01/2024	10:30:20	81	200.5	XLON	00384899471TRLO0.1.1
10/01/2024	10:30:20	90	200.5	TRQX	00384899472TRLO0.1.1
10/01/2024	10:30:20	95	200.5	XLON	00384899473TRLO0.1.1
10/01/2024	10:30:20	28	200.5	TRQX	00384899474TRLO0.1.1
10/01/2024	10:30:20	89	200.5	TRQX	00384899476TRLO0.1.1
10/01/2024	10:30:20	44	200.5	TRQX	00384899475TRLO0.1.1
10/01/2024	10:30:20	366	200.5	XLON	00384899477TRLO0.1.1
10/01/2024	10:30:20	542	200.5	XLON	00384899478TRLO0.1.1
10/01/2024	10:30:20	168	200.5	XLON	00384899480TRLO0.1.1
10/01/2024	10:30:20	266	200.5	XLON	00384899479TRLO0.1.1
10/01/2024	10:30:20	386	200.5	AQXE	00384899481TRLO0.1.1
10/01/2024	10:30:20	11	200.5	BATE	00384899482TRLO0.1.1
10/01/2024	10:30:20	11	200.5	CHIX	00384899483TRLO0.1.1
10/01/2024	10:30:20	108	200.5	XLON	00384899484TRLO0.1.1
10/01/2024	11:01:08	1320	200.5	XLON	00384904588TRLO0.1.1
10/01/2024	11:01:08	306	200.5	XLON	00384904589TRLO0.1.1
10/01/2024	11:01:08	542	200.5	XLON	00384904590TRLO0.1.1
10/01/2024	11:33:02	542	200	CHIX	00384909857TRLO0.1.1
10/01/2024	11:33:02	1084	200	XLON	00384909858TRLO0.1.1
10/01/2024	11:33:02	378	200	XLON	00384909859TRLO0.1.1
10/01/2024	11:33:02	164	200	XLON	00384909860TRLO0.1.1
10/01/2024	11:33:02	542	200	XLON	00384909861TRLO0.1.1
10/01/2024	11:33:07	224	200.5	CHIX	00384909869TRLO0.1.1
10/01/2024	11:33:07	74	200.5	CHIX	00384909870TRLO0.1.1
10/01/2024	11:33:07	226	200.5	CHIX	00384909871TRLO0.1.1
10/01/2024	11:41:00	361	199.4	XLON	00384910859TRLO0.1.1
10/01/2024	11:49:57	82	200.5	CHIX	00384911890TRLO0.1.1
10/01/2024	11:49:57	478	200.5	CHIX	00384911891TRLO0.1.1
10/01/2024	11:53:46	599	199.6	XLON	00384912363TRLO0.1.1
10/01/2024	11:53:46	2111	199.6	XLON	00384912364TRLO0.1.1
10/01/2024	11:53:46	386	199.6	AQXE	00384912365TRLO0.1.1
10/01/2024	12:16:34	91	200	CHIX	00384915683TRLO0.1.1
10/01/2024	12:16:34	154	200	CHIX	00384915684TRLO0.1.1
10/01/2024	12:16:34	297	200	CHIX	00384915685TRLO0.1.1
10/01/2024	12:16:36	1327	200	XLON	00384915687TRLO0.1.1
10/01/2024	12:16:36	480	200	XLON	00384915688TRLO0.1.1
10/01/2024	13:07:27	65	201.5	CHIX	00384922815TRLO0.1.1
10/01/2024	13:27:28	56	203.5	CHIX	00384926102TRLO0.1.1
10/01/2024	13:27:28	39	203.5	CHIX	00384926101TRLO0.1.1
10/01/2024	13:32:36	1147	204	XLON	00384927204TRLO0.1.1
10/01/2024	13:32:36	118	204	CHIX	00384927205TRLO0.1.1
10/01/2024	13:32:36	136	204	CHIX	00384927206TRLO0.1.1
10/01/2024	13:32:36	67	204	CHIX	00384927207TRLO0.1.1
10/01/2024	13:32:36	90	204	XLON	00384927209TRLO0.1.1
10/01/2024	13:32:36	221	204	CHIX	00384927208TRLO0.1.1
10/01/2024	13:32:36	161	204	XLON	00384927210TRLO0.1.1
10/01/2024	13:32:36	770	204	XLON	00384927211TRLO0.1.1
10/01/2024	13:32:36	456	204	AQXE	00384927213TRLO0.1.1
10/01/2024	14:09:28	615	205	XLON	00384934737TRLO0.1.1
10/01/2024	14:09:28	458	205	CHIX	00384934739TRLO0.1.1
10/01/2024	14:09:28	542	205	CHIX	00384934738TRLO0.1.1
10/01/2024	14:09:28	212	205	CHIX	00384934740TRLO0.1.1
10/01/2024	14:09:28	122	205	CHIX	00384934741TRLO0.1.1
10/01/2024	14:09:28	419	205	XLON	00384934742TRLO0.1.1
10/01/2024	14:09:28	1134	205	XLON	00384934743TRLO0.1.1
10/01/2024	14:09:28	266	205	XLON	00384934744TRLO0.1.1
10/01/2024	14:09:28	561	205	XLON	00384934745TRLO0.1.1
10/01/2024	14:09:28	257	205	XLON	00384934746TRLO0.1.1
10/01/2024	14:09:46	251	205.5	TRQX	00384934783TRLO0.1.1
10/01/2024	14:27:18	336	204.5	XLON	00384939228TRLO0.1.1
10/01/2024	15:02:00	299	205.5	AQXE	00384954402TRLO0.1.1
10/01/2024	15:02:00	386	205.5	AQXE	00384954404TRLO0.1.1
10/01/2024	15:02:00	87	205.5	AQXE	00384954403TRLO0.1.1
10/01/2024	15:02:00	79	205	BATE	00384954405TRLO0.1.1
10/01/2024	15:02:00	24	205	BATE	00384954407TRLO0.1.1
10/01/2024	15:02:00	146	205.5	XLON	00384954406TRLO0.1.1
10/01/2024	15:02:01	48	205	BATE	00384954411TRLO0.1.1
10/01/2024	15:02:01	88	205	BATE	00384954412TRLO0.1.1
10/01/2024	15:02:01	438	205	XLON	00384954414TRLO0.1.1
10/01/2024	15:02:01	105	205	CHIX	00384954413TRLO0.1.1
10/01/2024	15:02:04	753	206	TRQX	00384954464TRLO0.1.1
10/01/2024	15:11:37	33	205	AQXE	00384958483TRLO0.1.1
10/01/2024	15:11:37	31	205	CHIX	00384958484TRLO0.1.1
10/01/2024	15:11:37	283	205	AQXE	00384958485TRLO0.1.1
10/01/2024	15:11:37	146	205	AQXE	00384958486TRLO0.1.1
10/01/2024	15:11:37	406	205	CHIX	00384958487TRLO0.1.1
10/01/2024	15:44:30	427	205.5	XLON	00384971259TRLO0.1.1
10/01/2024	15:44:30	833	205.5	XLON	00384971258TRLO0.1.1
10/01/2024	15:44:30	1819	205.5	XLON	00384971260TRLO0.1.1
10/01/2024	15:45:42	251	206	TRQX	00384971900TRLO0.1.1
10/01/2024	15:46:18	542	204.5	CHIX	00384972166TRLO0.1.1
10/01/2024	15:46:19	9385	205	XLON	00384972170TRLO0.1.1
10/01/2024	15:46:24	692	205.5	BATE	00384972186TRLO0.1.1
10/01/2024	15:46:28	9901	205	XLON	00384972203TRLO0.1.1
10/01/2024	15:48:04	431	205	CHIX	00384973065TRLO0.1.1
10/01/2024	15:48:04	164	205	CHIX	00384973066TRLO0.1.1
10/01/2024	15:48:05	7588	205	XLON	00384973074TRLO0.1.1
10/01/2024	15:48:05	5983	205	XLON	00384973075TRLO0.1.1
10/01/2024	15:48:30	948	205	BATE	00384973298TRLO0.1.1
10/01/2024	15:48:51	327	205	CHIX	00384973434TRLO0.1.1
10/01/2024	15:48:51	89	205	CHIX	00384973433TRLO0.1.1
10/01/2024	15:48:51	1037	205	CHIX	00384973435TRLO0.1.1
10/01/2024	15:49:09	542	205	XLON	00384973645TRLO0.1.1
10/01/2024	15:49:44	282	205	CHIX	00384973932TRLO0.1.1
10/01/2024	15:49:44	139	205	CHIX	00384973933TRLO0.1.1
10/01/2024	15:50:24	199	205	CHIX	00384974247TRLO0.1.1
10/01/2024	15:51:01	542	205	XLON	00384974532TRLO0.1.1
10/01/2024	15:51:11	207	205	CHIX	00384974601TRLO0.1.1
10/01/2024	15:52:50	542	205	XLON	00384975358TRLO0.1.1
10/01/2024	15:54:19	941	204	XLON	00384976093TRLO0.1.1
10/01/2024	15:58:24	685	205	XLON	00384978226TRLO0.1.1
10/01/2024	16:00:09	542	205	XLON	00384979247TRLO0.1.1
10/01/2024	16:01:27	366	205	XLON	00384979927TRLO0.1.1
10/01/2024	16:01:27	176	205	XLON	00384979928TRLO0.1.1
10/01/2024	16:02:53	542	205	XLON	00384980424TRLO0.1.1
10/01/2024	16:04:11	259	205	XLON	00384980978TRLO0.1.1
10/01/2024	16:04:11	80	205	XLON	00384980979TRLO0.1.1
10/01/2024	16:04:11	203	205	XLON	00384980980TRLO0.1.1
10/01/2024	16:05:20	542	205	XLON	00384981452TRLO0.1.1
10/01/2024	16:06:29	542	205	XLON	00384981978TRLO0.1.1
10/01/2024	16:07:40	542	205	XLON	00384982576TRLO0.1.1
10/01/2024	16:07:48	7	205	TRQX	00384982615TRLO0.1.1
10/01/2024	16:07:50	1	205	AQXE	00384982647TRLO0.1.1
10/01/2024	16:08:26	7	205	TRQX	00384982865TRLO0.1.1
10/01/2024	16:08:47	542	205	XLON	00384983017TRLO0.1.1
10/01/2024	16:09:09	7	205	TRQX	00384983273TRLO0.1.1
10/01/2024	16:09:54	7	205	TRQX	00384983712TRLO0.1.1
10/01/2024	16:09:58	542	205	XLON	00384983743TRLO0.1.1
10/01/2024	16:10:20	384	204	AQXE	00384983935TRLO0.1.1
10/01/2024	16:10:20	242	204	AQXE	00384983936TRLO0.1.1
10/01/2024	16:10:20	42	204	BATE	00384983937TRLO0.1.1
10/01/2024	16:10:20	2789	204	CHIX	00384983938TRLO0.1.1
10/01/2024	16:10:20	4043	204	BATE	00384983939TRLO0.1.1
10/01/2024	16:10:20	474	204	TRQX	00384983940TRLO0.1.1
10/01/2024	16:10:20	1769	204	XLON	00384983941TRLO0.1.1
10/01/2024	16:10:20	542	204	XLON	00384983942TRLO0.1.1
10/01/2024	16:10:20	542	204	XLON	00384983943TRLO0.1.1
10/01/2024	16:10:20	941	204	XLON	00384983944TRLO0.1.1
10/01/2024	16:10:20	432	203.5	BATE	00384983945TRLO0.1.1
10/01/2024	16:10:20	110	203.5	BATE	00384983949TRLO0.1.1
10/01/2024	16:10:21	184	203.5	XLON	00384983950TRLO0.1.1
10/01/2024	16:10:21	234	203.5	XLON	00384983951TRLO0.1.1
10/01/2024	16:21:35	34	202.5	XLON	00384989069TRLO0.1.1
10/01/2024	16:21:50	409	202.5	CHIX	00384989179TRLO0.1.1
10/01/2024	16:21:50	632	202.5	XLON	00384989180TRLO0.1.1
10/01/2024	16:21:50	7	202.5	TRQX	00384989181TRLO0.1.1
10/01/2024	16:21:50	542	202.5	XLON	00384989182TRLO0.1.1
10/01/2024	16:21:50	542	202.5	XLON	00384989183TRLO0.1.1
10/01/2024	16:21:50	542	202.5	XLON	00384989184TRLO0.1.1
10/01/2024	16:24:55	359	202.5	XLON	00384990784TRLO0.1.1
10/01/2024	16:26:15	725	202.5	XLON	00384991420TRLO0.1.1
10/01/2024	16:27:23	542	202.5	XLON	00384991893TRLO0.1.1
10/01/2024	16:28:51	901	201.5	XLON	00384992550TRLO0.1.1
10/01/2024	16:28:54	3	201	XLON	00384992573TRLO0.1.1

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSFLFIDLAIILIS

Date		Source	Headline
21st Oct 2020	1:03 pm	RNS	Akili Presents New Data on EndeavorRx at AACAP
20th Oct 2020	1:08 pm	RNS	Vor Appoints Biotech Leader Matt Patterson to BOD
12th Oct 2020	1:00 pm	RNS	New Vedanta VE202 Data Presented at UEG Week
7th Oct 2020	1:03 pm	RNS	Akili Adds Award-Winning Marketing Leader as CMO
5th Oct 2020	12:00 pm	RNS	Alivio Awarded $3.3M from DoD to Advance ALV-304
1st Oct 2020	7:05 am	RNS	PureTech Appoints Biocon Founder Kiran Shaw to BOD
1st Oct 2020	7:00 am	RNS	Total Voting Rights
30th Sep 2020	2:00 pm	RNS	BARDA Awards Vedanta Up to $76.9M to Advance VE303
29th Sep 2020	12:00 pm	RNS	Alivio Adds Dr Harry Leider to Board of Directors
25th Sep 2020	4:35 pm	RNS	Price Monitoring Extension
23rd Sep 2020	7:00 am	RNS	PureTech Nasdaq Listing Progresses
18th Sep 2020	4:41 pm	RNS	Second Price Monitoring Extn
18th Sep 2020	4:35 pm	RNS	Price Monitoring Extension
18th Sep 2020	10:15 am	RNS	Price Monitoring Extension
16th Sep 2020	1:00 pm	RNS	Vedanta Appoints Drug Development Leader as CMO
4th Sep 2020	12:42 pm	RNS	Gelesis Presents Plenity Efficacy and Safety Data
4th Sep 2020	12:07 pm	RNS	Second Price Monitoring Extn
4th Sep 2020	12:02 pm	RNS	Price Monitoring Extension
3rd Sep 2020	12:02 pm	RNS	Price Monitoring Extension
28th Aug 2020	4:40 pm	RNS	Second Price Monitoring Extn
28th Aug 2020	4:36 pm	RNS	Price Monitoring Extension
27th Aug 2020	7:00 am	RNS	Half-year Report
26th Aug 2020	1:02 pm	RNS	Vor Appoints John King as Chief Commercial Officer
26th Aug 2020	12:40 pm	RNS	PRTC Receives $100M from Founded Entity Shares
26th Aug 2020	12:08 pm	RNS	Publication of Shareholder Circular
25th Aug 2020	2:05 pm	RNS	Sonde Makes Acquisition in Vocal Biomarker Space
6th Aug 2020	7:00 am	RNS	Notice of Results
5th Aug 2020	7:00 am	RNS	PureTech to Present at Wedbush PacGrow Conference
3rd Aug 2020	7:00 am	RNS	Total Voting Rights
30th Jul 2020	1:02 pm	RNS	Vor Appoints Life Science Leader to BOD
30th Jul 2020	12:07 pm	RNS	Second Price Monitoring Extn
30th Jul 2020	12:02 pm	RNS	Price Monitoring Extension
21st Jul 2020	12:08 pm	RNS	Second Price Monitoring Extn
21st Jul 2020	12:02 pm	RNS	Price Monitoring Extension
17th Jul 2020	7:00 am	RNS	Holding(s) in Company
16th Jul 2020	1:04 pm	RNS	Vor Appoints Biotech Finance Leader to BOD
14th Jul 2020	1:04 pm	RNS	Vor Names Oncology Drug Development Expert as CMO
8th Jul 2020	1:32 pm	RNS	Sonde Launches Voice Health Screening for COVID-19
8th Jul 2020	12:02 pm	RNS	Price Monitoring Extension
7th Jul 2020	12:03 pm	RNS	PureTech’s Vor Raises $110M Series B Financing
6th Jul 2020	7:01 am	RNS	Holding(s) in Company
6th Jul 2020	7:00 am	RNS	Holding(s) in Company
1st Jul 2020	7:00 am	RNS	Total Voting Rights
23rd Jun 2020	1:48 pm	RNS	Karuna Positive FDA End of Phase 2 Meeting
23rd Jun 2020	7:00 am	RNS	Akili Gets European Approval to Market EndeavorRx
22nd Jun 2020	2:00 pm	RNS	PRTC Presents New Immuno-oncology Data at AACR
22nd Jun 2020	7:00 am	RNS	PDMR Notification RSU Vesting
18th Jun 2020	12:01 pm	RNS	Gelesis China Deal $35M and up to $388M milestones
16th Jun 2020	7:00 am	RNS	Akili Granted FDA Clearance for ADHD Treatment
15th Jun 2020	12:07 pm	RNS	Second Price Monitoring Extn

Latest Share Chat

PureTech Regulatory News (PRTC)

Share Price Information for PureTech (PRTC)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

Login to your account

Quickpicks are a member only feature

Login to your account